EcoDrugPlus

Protein Farnesyltransferase Subunit Beta-Like

Ensembl ID : ENSSLDG00000023312
Gene Symbol: LOC111661543
3 Cross references
209 Possible Orthologues:

Protein Kinase C Alpha Type

Ensembl ID : ENSSLDG00000000416
Gene Symbol: LOC111659692
4 Cross references
213 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSSLDG00000017027
Gene Symbol: PRKCB
4 Cross references
78 Possible Orthologues:

Protein Kinase C Beta Type-Like

Ensembl ID : ENSSLDG00000023114
Gene Symbol: LOC111663270
3 Cross references
75 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSSLDG00000025034
Gene Symbol: PRKCD
3 Cross references
204 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSSLDG00000012823
Gene Symbol: PRKCD
3 Cross references
203 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSSLDG00000017025
Gene Symbol: PRKCE
2 Cross references
245 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSSLDG00000011173
Gene Symbol: PRKCE
3 Cross references
210 Possible Orthologues:

Protein Kinase C Epsilon Type-Like

Ensembl ID : ENSSLDG00000012234
Gene Symbol: LOC111668513
2 Cross references
210 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSSLDG00000001754
Gene Symbol: PRKCH
3 Cross references
224 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSSLDG00000011321
Gene Symbol: PRKCI
3 Cross references
87 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSSLDG00000017283
Gene Symbol: PRKCQ
3 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).